https://www.selleckchem.com/pr....oducts/L-Adrenaline-
Abacavir is part of WHO-recommended regimens to treat HIV in children under 15 years of age. In a pooled analysis across four studies, we describe abacavir population pharmacokinetics to investigate the influence of age, concomitant medications, malnutrition and formulation. A total of 230 HIV-infected African children were included, with median (range) age of 2.1 (0.1-12.8) years and weight of 9.8 (2.5-30. kg. The population pharmacokinetics of abacavir was described using nonlinear mixed-effects modelling. Abacavir
Like
Comment
Share
